Integra LifeSciences (IART) News Today $21.80 +0.09 (+0.41%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Here’s Why Integra LifeSciences Holdings Corporation (IART) Fell in Q3December 19 at 2:43 PM | msn.comCritical Review: Inspire Medical Systems (NYSE:INSP) & Integra LifeSciences (NASDAQ:IART)December 19 at 1:49 AM | americanbankingnews.comComparing Integra LifeSciences (NASDAQ:IART) and Alpha Tau Medical (NASDAQ:DRTS)December 18 at 2:25 AM | americanbankingnews.comIntegra Lifesciences Implements New Severance Program for ExecutivesDecember 18 at 2:10 AM | markets.businessinsider.comNotice to Long-Term Integra Lifesciences Holdings Corporation (IART) ShareholdersDecember 16, 2024 | markets.businessinsider.comLord Abbett & CO. LLC Sells 105,239 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)Lord Abbett & CO. LLC lessened its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 12.9% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 713,258 shares of the life sciences company's stock after sellDecember 16, 2024 | marketbeat.comFmr LLC Trims Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART)Fmr LLC trimmed its position in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 51.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 104,334 shares of the life sciences company's stock afterDecember 16, 2024 | marketbeat.comMetLife Investment Management LLC Buys 22,334 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)MetLife Investment Management LLC grew its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 129.1% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 39,638 shares of the life sciences company's stock after pDecember 8, 2024 | marketbeat.comBNP Paribas Financial Markets Buys 99,685 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)BNP Paribas Financial Markets lifted its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 824.5% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 111,775 shares of the life sciences company's stDecember 8, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Purchases 125,620 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)Charles Schwab Investment Management Inc. grew its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 15.3% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 944,282 shares of the life sciences company's stockDecember 8, 2024 | marketbeat.comIntegra LifeSciences Holdings Co. (NASDAQ:IART) Given Consensus Recommendation of "Reduce" by BrokeragesShares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Get Free Report) have earned an average recommendation of "Reduce" from the eight analysts that are currently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a sell recommendation, four haDecember 7, 2024 | marketbeat.comIntegra LifeSciences Holdings Co. (NASDAQ:IART) Stake Boosted by Systematic Financial Management LPSystematic Financial Management LP lifted its holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 53.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 611,746 shares of the life sciencDecember 6, 2024 | marketbeat.comIntegra (IART) Down 1.1% Since Last Earnings Report: Can It Rebound?December 5, 2024 | finance.yahoo.comSachem Head Capital Management LP Makes New Investment in Integra LifeSciences Holdings Co. (NASDAQ:IART)Sachem Head Capital Management LP bought a new position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 2,430,000 shares ofDecember 5, 2024 | marketbeat.comIntegra LifeSciences Holdings Co. (NASDAQ:IART) EVP Sells $41,072.00 in StockDecember 4, 2024 | insidertrades.comIntegra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Bridgewater Associates LPBridgewater Associates LP cut its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 73.9% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 29,533 shares of the life sciences company's sDecember 3, 2024 | marketbeat.comWalleye Capital LLC Acquires 207,196 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)Walleye Capital LLC lifted its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 758.7% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 234,506 shares of the life sciences company's stock after purDecember 2, 2024 | marketbeat.comQuantbot Technologies LP Increases Stock Position in Integra LifeSciences Holdings Co. (NASDAQ:IART)Quantbot Technologies LP boosted its holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 230.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 72,351 shares of the life sciences coDecember 1, 2024 | marketbeat.comFORA Capital LLC Takes $436,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART)FORA Capital LLC purchased a new position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 24,004 shares of the life sciences company's stock, valued at apNovember 30, 2024 | marketbeat.comGlenmede Trust Co. NA Acquires 405,624 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)Glenmede Trust Co. NA boosted its holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 125.9% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 727,781 shares of the life sciencesNovember 29, 2024 | marketbeat.comRubric Capital Management LP Acquires Shares of 293,083 Integra LifeSciences Holdings Co. (NASDAQ:IART)Rubric Capital Management LP bought a new stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 293,083 shares of the life sciences company's stock, vaNovember 27, 2024 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Acquires New Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART)Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 235,062 shaNovember 24, 2024 | marketbeat.comPrincipal Financial Group Inc. Has $7.29 Million Stock Position in Integra LifeSciences Holdings Co. (NASDAQ:IART)Principal Financial Group Inc. increased its holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 18.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 401,432 shares of the life sciNovember 20, 2024 | marketbeat.com52,850 Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) Purchased by GSA Capital Partners LLPGSA Capital Partners LLP acquired a new stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 52,850 shares of the life sciences company's stock, valued at approximately $960,0November 16, 2024 | marketbeat.comVersor Investments LP Invests $612,000 in Integra LifeSciences Holdings Co. (NASDAQ:IART)Versor Investments LP bought a new stake in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 33,700 shares of the life sciences company's stock, valued at approxNovember 14, 2024 | marketbeat.comIntegra's DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness ResearchNovember 13, 2024 | globenewswire.comIntegra LifeSciences Holdings Co. (NASDAQ:IART) Given Average Rating of "Reduce" by BrokeragesIntegra LifeSciences Holdings Co. (NASDAQ:IART - Get Free Report) has been assigned an average recommendation of "Reduce" from the nine research firms that are covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell rating, four have given a holNovember 12, 2024 | marketbeat.comEasterly Investment Partners LLC Sells 245,700 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)Easterly Investment Partners LLC lowered its holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 80.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 61,454 shaNovember 9, 2024 | marketbeat.comLeeward Investments LLC MA Sells 224,104 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)Leeward Investments LLC MA decreased its holdings in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 37.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 376,104 shares of the life sciences cNovember 8, 2024 | marketbeat.comIntegra LifeSciences Holdings Co. (NASDAQ:IART) Shares Bought by Olstein Capital Management L.P.Olstein Capital Management L.P. lifted its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 37.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 155,000 shares of the life sciences comNovember 7, 2024 | marketbeat.comIntegra Lifesciences names Mojdeh Poul as CEONovember 7, 2024 | finance.yahoo.comMorgan Stanley Remains a Sell on Integra Lifesciences (IART)November 6, 2024 | markets.businessinsider.comIntegra LifeSciences Holdings Corporation (NASDAQ:IART) Q3 2024 Earnings Call TranscriptNovember 5, 2024 | msn.comCitigroup Issues Positive Forecast for Integra LifeSciences (NASDAQ:IART) Stock PriceCitigroup raised their price objective on shares of Integra LifeSciences from $16.00 to $22.00 and gave the company a "sell" rating in a research report on Tuesday.November 5, 2024 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Releases Earnings ResultsIntegra LifeSciences (NASDAQ:IART - Get Free Report) announced its quarterly earnings data on Monday. The life sciences company reported $0.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.39 by $0.02. The firm had revenue of $380.80 million for the quarter, compared to analyst estimates of $375.81 million. Integra LifeSciences had a return on equity of 14.07% and a net margin of 1.51%. Integra LifeSciences's quarterly revenue was down .4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.76 earnings per share.November 5, 2024 | marketbeat.comIntegra LifeSciences Announces Q3 2024 Financial ResultsNovember 5, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Sana Biotechnology (SANA) and Integra Lifesciences (IART)November 5, 2024 | markets.businessinsider.comIntegra LifeSciences Shares Rally After Earnings Beat, CEO HiringNovember 5, 2024 | marketwatch.comIntegra LifeSciences Trims Outlook; Q2 Results Top Estimates; Names Mojdeh Poul As President And CEONovember 5, 2024 | markets.businessinsider.comWhy Is Integra LifeSciences Stock Soaring On Monday?November 4, 2024 | benzinga.comIntegra LifeSciences says Mojdeh Poul to succeed Jan De Witte as CEONovember 4, 2024 | markets.businessinsider.comIntegra LifeSciences Posts Upbeat Results, Joins Air Transport Services, Freshpet, Yum China And Other Big Stocks Moving Higher On MondayNovember 4, 2024 | msn.comIs Integra LifeSciences Holdings Corporation (NASDAQ:IART) Potentially Undervalued?November 4, 2024 | finance.yahoo.comIntegra Lifesciences Appoints Mojdeh Poul as CEONovember 4, 2024 | markets.businessinsider.comIntegra LifeSciences Holdings Corporation (IART) Q3 2024 Earnings Call TranscriptNovember 4, 2024 | seekingalpha.comIntegra LifeSciences (NASDAQ:IART) Shares Gap Up - Here's What HappenedIntegra LifeSciences (NASDAQ:IART) Shares Gap Up - Time to Buy?November 4, 2024 | marketbeat.comIntegra LifeSciences Holdings Corporation 2024 Q3 - Results - Earnings Call PresentationNovember 4, 2024 | seekingalpha.comIntegra LifeSciences (NASDAQ:IART) Issues Q4 Earnings GuidanceIntegra LifeSciences (NASDAQ:IART) updated its fourth quarter earnings guidance. The company provided EPS guidance of $0.81-0.89 for the period, compared to the consensus estimate of $0.87. The company also issued revenue guidance of $441-451 millionillion, compared to the consensus estimate of $448.48 millionillion.November 4, 2024 | marketbeat.comIntegra LifeSciences Reports Third Quarter 2024 Financial ResultsNovember 4, 2024 | globenewswire.comIntegra LifeSciences Announces Appointment of Mojdeh Poul as President and Chief Executive OfficerNovember 4, 2024 | globenewswire.com Get Integra LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it. Click here to watch this demo and decide for yourself. IART Media Mentions By Week IART Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IART News Sentiment▼0.630.60▲Average Medical News Sentiment IART News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IART Articles This Week▼74▲IART Articles Average Week Get Integra LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ITGR News ATRC News ATEC News OFIX News SRDX News ANGO News ARAY News RMTI News RSLS News ABT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IART) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integra LifeSciences Holdings Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Integra LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IART Stock Alerts